Radiolabeling of HER2-specific Affibody® molecule with F-18
- 1 July 2008
- journal article
- research article
- Published by Elsevier in Journal of Fluorine Chemistry
- Vol. 129 (9) , 799-806
- https://doi.org/10.1016/j.jfluchem.2008.06.021
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- 99mTc-maEEE-ZHER2:342, an Affibody Molecule-Based Tracer for the Detection of HER2 Expression in Malignant TumorsBioconjugate Chemistry, 2007
- Affibody molecules: potential forin vivoimaging of molecular targets for cancer therapyExpert Opinion on Biological Therapy, 2007
- Tumor Imaging Using a Picomolar Affinity HER2 Binding Affibody MoleculeCancer Research, 2006
- Evaluation of ((4-Hydroxyphenyl)ethyl)maleimide for Site-Specific Radiobromination of Anti-HER2 AffibodyBioconjugate Chemistry, 2005
- Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitorsNature Biotechnology, 2004
- Synthesis of a New Heterobifunctional Linker, N-[4-(Aminooxy)butyl]maleimide, for Facile Access to a Thiol-Reactive 18F-Labeling AgentBioconjugate Chemistry, 2003
- Resolution uniformity and sensitivity of the NIH ATLAS small animal PET scanner: Comparison to simulated LSO scanners without depth-of-interaction capabilityIEEE Transactions on Nuclear Science, 2003
- Assessment of HER2 status in breast cancerEuropean Journal Of Cancer, 2000
- Synthesis of 18F‐labelled N‐(p‐[18F]fluorophenyl)maleimide and its derivatives for labelling monoclonal antibody with 18FJournal of Labelled Compounds and Radiopharmaceuticals, 1989
- Cross-linking of protein by ω-maleimido alkanoylN-hydroxysuccinimido estersProtein Journal, 1983